Syrosingopine |
| Katalog-Nr.GC39536 |
Syrosingopin (Su 3118) ist ein oral aktiver dualer Inhibitor der Laktattransporter (MCT1/MCT4), der in Kombination mit Metformin die Glykolyse reduzieren und eine synthetische LetalitÄt in Krebszellen induzieren kann.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 84-36-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Syrosingopine (Su 3118) is an antihypertensive agent. Syrosingopine can decrease brain dopamine levels[1][2].
[1]. Benjamin D, et al. Syrosingopine sensitizes cancer cells to killing by metformin. Sci Adv. 2016 Dec 23;2(12):e1601756. [2]. Furukawa T, et al. Selective depleting effect of syrosingopine on brain catecholamine levels with relation to morphine analgesia in the rat. Pharmacol Biochem Behav. 1976 Apr;4(4):419-25.
Average Rating: 5 (Based on Reviews and 4 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *